Zhong M, Liu Z P, Xu L J, Wang Z Y, Wang G T
Faculty of Pharmacy, Shandong Medical University, Jinan.
Yao Xue Xue Bao. 1996;31(11):837-43.
A series of 9-(N4-substituted acetaldehyde thiosemicarbazone) adenines were synthesized and evaluated for antiherpes virus activity. Compounds 4a-l were prepared by condensation of 9-(acetaldehyde) adenine(6) and the corresponding N4-substituted thiosemicarbazides (10). The antiviral effects of all compounds 4a-l were tested in vitro in primary rabbit kidney cell cultures infected with herpes simplex virus type 1 (HSV-1) and varicella-herpes zoster virus (VZV), and in primary human embryo cell cultures infected with herpes simplex virus type 2 (HSV-2). The results showed that the minimum inhibitory concentrations (MIC) of 4e and 4f for HSV-1 and VZV were 20, 40, 20 and 20 micrograms.ml-1, respectively, and other compounds were 200 micrograms.ml-1. For HSV-2, the MIC of all tested compounds were 300 micrograms.ml-1. We also evaluated the antiherpetic effect of 4e (and 4f) by combination with acyclovir (ACV) in the ratio of 1:1 in vitro. The MIC of the combined compounds were 2 micrograms.ml-1 for 4e and 6 micrograms.ml-1 for 4f, while their minimum cytotoxicities (MCC) in the cell were markedly reduced compared with the individual compounds.
合成了一系列9-(N4-取代乙醛缩氨基硫脲)腺嘌呤,并对其抗疱疹病毒活性进行了评估。化合物4a-l是通过9-(乙醛)腺嘌呤(6)与相应的N4-取代缩氨基硫脲(10)缩合制备的。在感染1型单纯疱疹病毒(HSV-1)和水痘-带状疱疹病毒(VZV)的原代兔肾细胞培养物以及感染2型单纯疱疹病毒(HSV-2)的原代人胚胎细胞培养物中,对所有化合物4a-l的抗病毒效果进行了体外测试。结果表明,4e和4f对HSV-1和VZV的最低抑菌浓度(MIC)分别为20、40、20和20微克·毫升-1,其他化合物为200微克·毫升-1。对于HSV-2,所有测试化合物的MIC均为300微克·毫升-1。我们还在体外以1:1的比例将4e(和4f)与阿昔洛韦(ACV)联合使用,评估其抗疱疹作用。联合化合物的MIC对于4e为2微克·毫升-1,对于4f为6微克·毫升-1,而它们在细胞中的最低细胞毒性(MCC)与单个化合物相比明显降低。